WIRTH PETER 4
4 · ROFIN SINAR TECHNOLOGIES INC · Filed Feb 12, 2013
Insider Transaction Report
Form 4
WIRTH PETER
Director
Transactions
- Purchase
Common Stock - RSTI
2013-02-11$17.11/sh+20,000$342,200→ 32,600 total - Expiration (Short)
Employee Stock Option Right to Buy
2013-02-11+0→ 20,000 totalExercise: $28.50From: 2008-03-15Exp: 2017-03-15→ Common Stock - RSTI (0 underlying) - Sale
Common Stock - RSTI
2013-02-11$27.81/sh−20,000$556,274→ 12,600 total - Purchase
Employee Stock Option Right to Buy
2013-02-11$17.11/sh+20,000$342,200→ 0 totalExercise: $17.11From: 2006-03-17Exp: 2015-03-15→ Common Stock - RSTI (20,000 underlying) - Expiration (Short)
Employee Stock Option Right to Buy
2013-02-11+0→ 80,000 totalExercise: $26.05From: 2007-03-16Exp: 2016-03-16→ Common Stock - RSTI (0 underlying) - Expiration (Short)
Employee Stock Option Right to Buy
2013-02-11+0→ 5,000 totalExercise: $40.20From: 2009-03-19Exp: 2018-03-19→ Common Stock - RSTI (0 underlying) - Expiration (Short)
Common Stock - RSTI
2013-02-11+0→ 6,500 total(indirect: By Spouse)
Footnotes (6)
- [F1]Shares were exercised under the Rofin-Sinar Technologies Inc. Equity Incentive Plan (the Plan). Shares were purchased at the exercise price and then sold at the market price on the same day. Shares were all sold in individual transactions between $27.78 and $27.92. Average price for the shares sold was $27.8137.
- [F2]Value represents the exercise price of the shares granted under the Plan.
- [F3]No transaction being reported at this time - only reporting holdings as of this date.
- [F4]Grants to purchase shares of common stock under the Plan are exercisable in 20% increments on each of the first five anniversaries of the date of grant and expire following the tenth anniversary of the date of grant.
- [F5]Number represents the number of available shares remaining under the particular grant date. Shares are vested but not yet beneficially owned, only outstanding under the plan.
- [F6]Number represents the number of available shares remaining under the particular grant date. 4,000 shares are currently vested and exercisable and the remaining 1,000 shares have not yet vested. None of these shares are beneficially owned yet.